JPRN-jRCT2080220121未知3 期
Phase 3 study of cetirizine dry syrup in children suffering from cutaneous disease accompanied by pruritus.
GlaxoSmithKline K.K.0 个研究点目标入组 60 人开始时间: 2005年9月13日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 2age old 至 <= 14age old（—）
入选标准
- •Age: 2 to 14, Children with cutaneous disease accompanied with pruritus, patients eligible for evaluation of pruitus, etc.
排除标准
- 未提供
研究者
相似试验
未知
3 期
Phase 3 study of cetirizine dry syrup in children suffering from perennial allergic rhinitis(Open study)Perennial allergic rhinitisJPRN-jRCT2080220123GlaxoSmithKline K.K.30
未知
3 期
Phase 3 study of cetirizine dry syrup in children suffering from atopic dermatitis.Atopic dermatitisJPRN-jRCT2080220120GlaxoSmithKline K.K.278
未知
3 期
Phase 3 study of cetirizine dry syrup in children suffering from perennial allergic rhinitis (Comparative study)Perennial Allergic RhinitisJPRN-jRCT2080220122GlaxoSmithKline K.K.286
已完成
3 期
Study Of Cutaneous Disease Accompanied With Pruritus In PediatricsPruritusNCT00257582GlaxoSmithKline60
已完成
1 期
use of cetirizine in infants 3-6 monthsCetirizine.IRCT20110531006660N8Mazandaran University of Medical Sciences30